踩上脑机接口概念风口，这家仅12名员工的中概生物科技公司——脑再生科技（RGC.O）上演了一场美股“神话”。当地时间6月5日，脑再生科技收跌0.82%，报624.95美元/股。至此，公司总市值已高达81.32亿美元（折合584亿元人民币），公司股价年内上涨超125倍。脑再生科技是一家早期生物科学公司，专注于研究、开发和商业化中药，用于治疗神经认知障碍和退化，特别是注意力缺陷多动障碍（ADHD）和...
Source Link踩上脑机接口概念风口，这家仅12名员工的中概生物科技公司——脑再生科技（RGC.O）上演了一场美股“神话”。当地时间6月5日，脑再生科技收跌0.82%，报624.95美元/股。至此，公司总市值已高达81.32亿美元（折合584亿元人民币），公司股价年内上涨超125倍。脑再生科技是一家早期生物科学公司，专注于研究、开发和商业化中药，用于治疗神经认知障碍和退化，特别是注意力缺陷多动障碍（ADHD）和...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.